TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer

H-ferritin (HFn) nanocarrier is emerging as a promising theranostic platform for tumor diagnosis and therapy, which can specifically target tumor cells via binding transferrin receptor 1 (TfR1). This led us to investigate the therapeutic function of TfR1 in GC. The clinical significance of TfR1 was...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Xiaojing, Fan, Kelong, Wang, Lin, Ying, Xiangji, Sanders, Andrew J., Guo, Ting, Xing, Xiaofang, Zhou, Meng, Du, Hong, Hu, Ying, Ding, Huirong, Li, Ziyu, Wen, Xianzi, Jiang, Wenguo, Yan, Xiyun, Ji, Jiafu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002446/
https://www.ncbi.nlm.nih.gov/pubmed/32024821
http://dx.doi.org/10.1038/s41419-020-2272-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002446/
https://www.ncbi.nlm.nih.gov/pubmed/32024821
http://dx.doi.org/10.1038/s41419-020-2272-z

Ejemplares similares